← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. ALGN
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

ALGN logoAlign Technology, Inc. (ALGN) P/E Ratio History

Historical price-to-earnings valuation from 2004 to 2026

Current P/E
29.8
Undervalued
5Y Avg P/E
48.2
-38% vs avg
PE Percentile
20%
Below Avg
PEG Ratio
N/A
N/A
TTM EPS$6.00
Price$168.39
5Y PE Range24.3 - 86.9
Earnings Yield3.36%

Loading P/E history...

ALGN Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
29.8vs48.2
-38%
Cheap vs History
vs. Healthcare
29.8vs22.3
+34%
Above Sector
vs. S&P 500
29.8vs25.1
+19%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 1% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Align Technology, Inc. (ALGN) trades at a price-to-earnings ratio of 29.8x, with a stock price of $168.39 and trailing twelve-month earnings per share of $6.00.

The current P/E is 38% below its 5-year average of 48.2x. Over the past five years, ALGN's P/E has ranged from a low of 24.3x to a high of 86.9x, placing the current valuation at the 20th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, ALGN trades at a 34% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, ALGN trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ALGN DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ALGN P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HSIC logoHSICHenry Schein, Inc.
$8B21.66.84+7%
NVST logoNVSTEnvista Holdings Corp
$4B86.758.08+104%
IDXX logoIDXXIDEXX Laboratories, Inc.
$45B43.73.06+23%
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
ISRG logoISRGIntuitive Surgical, Inc.
$161B57.62.65Best+23%
TMDX logoTMDXTransMedics Group, Inc.
$3B15.0Lowest-+382%Best
MMM logoMMM3M Company
$75B24.0--21%
IPGP logoIPGPIPG Photonics Corporation
$4B139.2-+118%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

ALGN Historical P/E Data (2004–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1$171.37$5.9628.8x-54%
FY2025 Q4Wed Dec 31 2025 00:00:00 GM$156.15$5.6627.6x-56%
FY2025 Q3$125.22$5.1624.3x-61%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$189.33$5.9331.9x-49%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$158.86$5.4928.9x-54%
FY2024 Q4$208.51$5.6137.2x-41%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$254.32$5.8643.4x-31%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$241.43$5.8941.0x-34%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$327.92$6.0754.0x-14%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$274.00$5.8247.1x-25%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$305.32$4.7264.7x+3%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$353.64$4.0786.9x+39%

Average P/E for displayed period: 62.6x

Full ALGN Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See ALGN's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ALGN Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ALGN vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

ALGN — Frequently Asked Questions

Quick answers to the most common questions about buying ALGN stock.

Is ALGN stock overvalued or undervalued?

ALGN trades at 29.8x P/E, below its 5-year average of 48.2x. At the 20th percentile of historical range, the stock is priced at a discount to its own history.

How does ALGN's valuation compare to peers?

Align Technology, Inc. P/E of 29.8x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is ALGN's PEG ratio?

ALGN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2004-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ALGN P/E Ratio History (2004–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.